MedTrace Logo

Myocardial Perfusion and Scarring in Congenital Heart Disease

NCT01639937 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 18

Last updated 2021-12-02

No results posted yet for this study

Summary

Background:

\- People with congenital heart disease may develop heart failure earlier that those who do not have the disease. One theory to explain this is that the heart s own blood supply may be different in people with congenital heart disease. Problems with this blood supply can severely damage the heart. This damage can be studied with a heart imaging test called a cardiac magnetic resonance imaging (MRI) scan. Researchers want to use this type of scan to look at the blood supply to the heart in people with congenital heart disease.

Objectives:

\- To learn more about the blood supply to the heart in people with congenital heart disease.

Eligibility:

\- Individuals at least 18 years of age who have heart defects caused by congenital heart disease.

Design:

* Participants will be screened with a physical exam and medical history. Blood and urine samples will be collected.
* Participants will have a cardiac MRI scan to look at the blood flow to the heart.
* Participants will also have a heart stress test to measure heart function during exercise.
* Other imaging studies of the heart may be performed to collect more information on heart function.

Conditions

  • Congenital Heart Disease

Sponsors & Collaborators

  • Children's National Research Institute

    collaborator OTHER

  • Suburban Hospital

    collaborator OTHER

  • National Heart, Lung, and Blood Institute (NHLBI)

    lead NIH

Principal Investigators

  • Arlene Sirajuddin, M.D. · National Heart, Lung, and Blood Institute (NHLBI)

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-10-24
Primary Completion
2017-04-01
Completion
2019-12-12

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01639937 on ClinicalTrials.gov